Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-05-23 16:29:54
Reporting Period:
Accepted Time:
2019-05-23 16:29:54
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1618835 Evofem Biosciences Inc. EVFM () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535065 P. Kim Kamdar C/o Domain Associates, Llc
202 Carnegie Center, Suite 104
Princeton NJ 08540
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-21 655 $5.07 0 No 4 S Indirect By Domain Associates, LLC
Common Stock Acquisiton 2019-05-22 4,287 $0.00 4,287 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Domain Associates, LLC
No 4 J Direct
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.073 to $5.074. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The Reporting Person is a managing member of Domain Associates, LLC. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by such entity, however, she disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed her pecuniary interest therein and/or that are not actually distributed to her.
  3. Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members.